LYNKUET DIN 02559714
Health Canada record
| Active ingredient(s) | ELINZANETANT 60 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G02CX07 ELINZANETANT |
| Original market date | 14-Jul-2026 |
| Current status date | 14-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35723 | 2025-07-23 | New Drug Submission (NDS) |